+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Bronchitis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026

  • ID: 4851495
  • Report
  • March 2019
  • Region: Global
  • 176 pages
  • Transparency Market Research
1 of 2

Global Bronchitis Treatment market: Overview 

This report analyzes the current and future scenario of the global bronchitis treatment market. Rise in geriatric population, high incidence of bronchitis, and increase in cigarette smoking patient pool are major drivers of the global market. 

The global bronchitis treatment market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to segments based on type, drug class, distribution channel, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global bronchitis treatment market. 

Global Bronchitis Treatment Market: Key Segments 

The global bronchitis treatment market has been segmented based on type, drug class, distribution channel, and region. Furthermore, in terms of type, the market has been divided into chronic bronchitis and acute bronchitis. The chronic bronchitis segment is likely to account for a leading share of the global market during the forecast period owing to high morbidity and mortality rate. Based on drug class, the bronchitis treatment market has been classified into antibiotics, anti-inflammatory drugs, bronchodilators, and mucolytics. In terms of distribution channel, the market has been segregated into hospital pharmacies, retail pharmacies, and online pharmacies. The retail pharmacies segment held a significant share of the market in 2017 due to a rise in the sale of over-the-counter bronchitis therapeutics. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. 

Global Bronchitis Treatment Market: Regional Outlook 

In terms of region, the global bronchitis treatment market has been segmented into five major regions and key countries/sub-regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). The market size and forecast for each of these regions and countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions. 

Companies Mentioned in Report

The report also profiles major players in the global bronchitis treatment market based on various attributes such as company overview, financial overview, type portfolio, business strategies, and recent developments. Key players in the global bronchitis treatment market are AstraZeneca, Novartis AG, GlaxoSmithKline plc, Dr. Reddy's Laboratories Ltd., Melinta Therapeutics, Sanofi Aventis, and Boehringer Ingelheim International GmbH.

Note: Product cover images may vary from those shown
2 of 2
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights

2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology

3. Executive Summary
3.1. Global Bronchitis Treatment Market: Market Snapshot

4. Market Overview
4.1. Global Bronchitis Treatment Market: Type Overview
4.2. Global Bronchitis Treatment Market: Key Industry Developments
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Bronchitis Treatment Market Revenue Projections, 2016-2026
4.5. Porter’s Five Forces Analysis
4.6. Global Bronchitis Treatment Market Outlook

5. Market Outlook
5.1. Pipeline Analysis
5.2. Key Market Trends
5.3. Disease Epidemiology

6. Global Bronchitis Treatment Market Analysis, by Type
6.1. Key Findings
6.2. Introduction
6.3. Global Bronchitis Treatment Market Value Share and Attractiveness Analysis, by Type
6.4. Global Bronchitis Treatment Market Value Forecast, by Type
6.4.1. Acute Bronchitis
6.4.2. Chronic Bronchitis
6.5. Global Bronchitis Treatment Market Analysis, by Type

7. Global Bronchitis Treatment Market Analysis and Forecast, by Drug Class
7.1. Key Findings
7.2. Introduction
7.3. Global Bronchitis Treatment Market Value Share and Attractiveness Analysis, by Drug Class
7.4. Global Bronchitis Treatment Market Value Forecast, by Drug Class
7.4.1. Antibiotics
7.4.2. Anti-inflammatory Drugs
7.4.3. Bronchodilators
7.4.4. Mucolytics
7.5. Global Bronchitis Treatment Market Analysis, by Drug Class

8. Global Bronchitis Treatment Market Analysis, by Distribution Channel
8.1. Key Findings
8.2. Introduction
8.3. Global Bronchitis Treatment Market Value Share and Attractiveness Analysis, by Distribution Channel
8.4. Global Bronchitis Treatment Market Value Forecast, by Distribution Channel
8.4.1. Hospital Pharmacies
8.4.2. Retail Pharmacies
8.4.3. Online Pharmacies
8.5. Global Bronchitis Treatment Market Analysis, by Distribution Channel

9. Global Bronchitis Treatment Market Analysis, by Region
9.1. Global Bronchitis Treatment Market Scenario, by Country
9.2. Global Bronchitis Treatment Market Value Share and Attractiveness Analysis, by Region
9.3. Global Bronchitis Treatment Market Value Forecast, by Region
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa

10. North America Bronchitis Treatment Market Analysis
10.1. Key Findings
10.2. North America Bronchitis Treatment Market Overview
10.3. North America Bronchitis Treatment Market Value Share and Attractiveness Analysis, by Country
10.4. North America Bronchitis Treatment Market Forecast, by Country
10.4.1. U.S.
10.4.2. Canada
10.5. North America Bronchitis Treatment Market Value Share Analysis, by Type
10.6. North America Bronchitis Treatment Market Forecast, by Type
10.6.1. Acute Bronchitis
10.6.2. Chronic Bronchitis
10.7. North America Bronchitis Treatment Market Value Share Analysis, by Drug Class
10.8. North America Bronchitis Treatment Market Forecast, by Drug Class
10.8.1. Antibiotics
10.8.2. Anti-inflammatory Drugs
10.8.3. Bronchodilators
10.8.4. Mucolytics
10.9. North America Bronchitis Treatment Market Value Share Analysis, by Distribution Channel
10.10. North America Bronchitis Treatment Market Forecast, by Distribution Channel
10.10.1. Hospital Pharmacies
10.10.2. Retail Pharmacies
10.10.3. Online Pharmacies
10.11. North America Bronchitis Treatment Market Attractiveness Analysis

11. Europe Bronchitis Treatment Market Analysis
11.1. Key Findings
11.2. Europe Bronchitis Treatment Market Overview
11.3. Europe Bronchitis Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
11.4. Europe Bronchitis Treatment Market Forecast, by Country/Sub-region
11.4.1. Germany
11.4.2. U.K.
11.4.3. France
11.4.4. Italy
11.4.5. Spain
11.4.6. Rest of Europe
11.5. Europe Bronchitis Treatment Market Value Share Analysis, by Type
11.6. Europe Bronchitis Treatment Market Forecast, by Type
11.6.1. Acute Bronchitis
11.6.2. Chronic Bronchitis
11.7. Europe Bronchitis Treatment Market Value Share Analysis, by Drug Class
11.8. Europe Bronchitis Treatment Market Forecast, by Drug Class
11.8.1. Antibiotics
11.8.2. Anti-inflammatory Drugs
11.8.3. Bronchodilators
11.8.4. Mucolytics
11.9. Europe Bronchitis Treatment Market Value Share Analysis, by Distribution Channel
11.10. Europe Bronchitis Treatment Market Forecast, by Distribution Channel
11.10.1. Hospital Pharmacies
11.10.2. Retail Pharmacies
11.10.3. Online Pharmacies
11.11. Europe Bronchitis Treatment Market Attractiveness Analysis

12. Asia Pacific Bronchitis Treatment Market Analysis
12.1. Key Findings
12.2. Asia Pacific Bronchitis Treatment Market Overview
12.3. Asia Pacific Bronchitis Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
12.4. Asia Pacific Bronchitis Treatment Market Forecast, by Country/Sub-region
12.4.1. China
12.4.2. India
12.4.3. Japan
12.4.4. Australia & New Zealand
12.4.5. Rest of Asia Pacific
12.5. Asia Pacific Bronchitis Treatment Market Value Share Analysis, by Type
12.6. Asia Pacific Bronchitis Treatment Market Forecast, by Type
12.6.1. Acute Bronchitis
12.6.2. Chronic Bronchitis
12.7. Asia Pacific Bronchitis Treatment Market Value Share Analysis, by Drug Class
12.8. Asia Pacific Bronchitis Treatment Market Forecast, by Drug Class
12.8.1. Antibiotics
12.8.2. Anti-inflammatory Drugs
12.8.3. Bronchodilators
12.8.4. Mucolytics
12.9. Asia Pacific Bronchitis Treatment Market Value Share Analysis, by Distribution Channel
12.10. Asia Pacific Bronchitis Treatment Market Forecast, by Distribution Channel
12.10.1. Hospital Pharmacies
12.10.2. Retail Pharmacies
12.10.3. Online Pharmacies
12.11. Asia Pacific Bronchitis Treatment Market Attractiveness Analysis

13. Latin America Bronchitis Treatment Market Analysis
13.1. Key Findings
13.2. Latin America Bronchitis Treatment Market Overview
13.3. Latin America Bronchitis Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.4. Latin America Bronchitis Treatment Market Forecast, by Country/Sub-region
13.4.1. Brazil
13.4.2. Mexico
13.4.3. Rest of Latin America
13.5. Latin America Bronchitis Treatment Market Value Share Analysis, by Type
13.6. Latin America Bronchitis Treatment Market Forecast, by Type
13.6.1. Acute Bronchitis
13.6.2. Chronic Bronchitis
13.7. Latin America Bronchitis Treatment Market Value Share Analysis, by Drug Class
13.8. Latin America Bronchitis Treatment Market Forecast, by Drug Class
13.8.1. Antibiotics
13.8.2. Anti-inflammatory Drugs
13.8.3. Bronchodilators
13.8.4. Mucolytics
13.9. Latin America Bronchitis Treatment Market Value Share Analysis, by Distribution Channel
13.10. Latin America Bronchitis Treatment Market Forecast, by Distribution Channel
13.10.1. Hospital Pharmacies
13.10.2. Retail Pharmacies
13.10.3. Online Pharmacies
13.11. Latin America Bronchitis Treatment Market Attractiveness Analysis

14. Middle East & Africa Bronchitis Treatment Market Analysis
14.1. Key Findings
14.2. Middle East & Africa Bronchitis Treatment Market Overview
14.3. Middle East & Africa Bronchitis Treatment Market Value Share Analysis, by Country/Sub-region
14.4. Middle East & Africa Bronchitis Treatment Market Forecast, by Country/Sub-region
14.4.1. GCC Countries
14.4.2. South Africa
14.4.3. Rest of Middle East and Africa
14.5. Middle East & Africa Bronchitis Treatment Market Value Share Analysis, by Type
14.6. Middle East & Africa Bronchitis Treatment Market Forecast, by Type
14.6.1. Acute Bronchitis
14.6.2. Chronic Bronchitis
14.7. Middle East & Africa Bronchitis Treatment Market Value Share Analysis, by Drug Class
14.8. Middle East & Africa Bronchitis Treatment Market Forecast, by Drug Class
14.8.1. Antibiotics
14.8.2. Anti-inflammatory Drugs
14.8.3. Bronchodilators
14.8.4. Mucolytics
14.9. Middle East & Africa Bronchitis Treatment Market Value Share Analysis, by Distribution Channel
14.10. Middle East & Africa Bronchitis Treatment Market Forecast, by Distribution Channel
14.10.1. Hospital Pharmacies
14.10.2. Retail Pharmacies
14.10.3. Online Pharmacies
14.11. Middle East & Africa Bronchitis Treatment Market Attractiveness Analysis

15. Competition Landscape
15.1. Bronchitis Treatment Market Share Analysis, by Company, 2017
15.2. Competition Matrix
15.3. Company Profiles
15.3.1. AstraZeneca
15.3.1.1. Company Details
15.3.1.2. Business Overview
15.3.1.3. Financial Overview
15.3.1.4. Strategic Overview
15.3.1.5. SWOT Analysis
15.3.2. Boehringer Ingelheim International GmbH
15.3.2.1. Company Details
15.3.2.2. Business Overview
15.3.2.3. Financial Overview
15.3.2.4. Strategic Overview
15.3.2.5. SWOT Analysis
15.3.3. GlaxoSmithKline plc
15.3.3.1. Company Details
15.3.3.2. Business Overview
15.3.3.3. Financial Overview
15.3.3.4. Strategic Overview
15.3.3.5. SWOT Analysis
15.3.4. Novartis AG
15.3.4.1. Company Details
15.3.4.2. Business Overview
15.3.4.3. Financial Overview
15.3.4.4. Strategic Overview
15.3.4.5. SWOT Analysis
15.3.5. Melinta Therapeutics
15.3.5.1. Company Details
15.3.5.2. Business Overview
15.3.5.3. Financial Overview
15.3.5.4. Strategic Overview
15.3.5.5. SWOT Analysis
15.3.6. Dr Reddy's Laboratories Ltd
15.3.6.1. Company Details
15.3.6.2. Business Overview
15.3.6.3. Financial Overview
15.3.6.4. Strategic Overview
15.3.6.5. SWOT Analysis
15.3.7. Sanofi S.A.
15.3.7.1. Company Details
15.3.7.2. Business Overview
15.3.7.3. Financial Overview
15.3.7.4. Strategic Overview
15.3.7.5. SWOT Analysis
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll